
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intrahepatic CD69+Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression
Elena Bruni, Matteo Cimino, Matteo Donadon, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004579-e004579
Open Access | Times Cited: 33
Elena Bruni, Matteo Cimino, Matteo Donadon, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004579-e004579
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
The emerging roles of γδ T cells in cancer immunotherapy
Sofia Mensurado, Rafael Blanco-Domínguez, Bruno Silva‐Santos
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 3, pp. 178-191
Closed Access | Times Cited: 198
Sofia Mensurado, Rafael Blanco-Domínguez, Bruno Silva‐Santos
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 3, pp. 178-191
Closed Access | Times Cited: 198
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Zhifei Gao, Yifeng Bai, Anqi Lin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 73
Zhifei Gao, Yifeng Bai, Anqi Lin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 73
A close look at current γδ T-cell immunotherapy
Ling Ma, Yanmin Feng, Zishan Zhou
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Ling Ma, Yanmin Feng, Zishan Zhou
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer
Yuchen Li, Yinfeng Gu, Pengyue Yang, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 1-14
Open Access | Times Cited: 12
Yuchen Li, Yinfeng Gu, Pengyue Yang, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 1-14
Open Access | Times Cited: 12
Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy
Megan Yuan, Wenjun Wang, Isobel Hawes, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Megan Yuan, Wenjun Wang, Isobel Hawes, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Cancer immunotherapy by γδ T cells
Adrian Hayday, Julie Déchanet‐Merville, Jamie Rossjohn, et al.
Science (2024) Vol. 386, Iss. 6717
Open Access | Times Cited: 9
Adrian Hayday, Julie Déchanet‐Merville, Jamie Rossjohn, et al.
Science (2024) Vol. 386, Iss. 6717
Open Access | Times Cited: 9
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging
Ayako Kurioka, Paul Klenerman
Seminars in Immunology (2023) Vol. 69, pp. 101816-101816
Open Access | Times Cited: 18
Ayako Kurioka, Paul Klenerman
Seminars in Immunology (2023) Vol. 69, pp. 101816-101816
Open Access | Times Cited: 18
NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis
Sonja Marinović, Maja Lenartić, Karlo Mladenić, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 15
Sonja Marinović, Maja Lenartić, Karlo Mladenić, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 15
Local γδ T cells: translating promise to practice in cancer immunotherapy
Iva Zlatareva, Yin Wu
British Journal of Cancer (2023) Vol. 129, Iss. 3, pp. 393-405
Open Access | Times Cited: 14
Iva Zlatareva, Yin Wu
British Journal of Cancer (2023) Vol. 129, Iss. 3, pp. 393-405
Open Access | Times Cited: 14
Dynamics of The Γδtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer
Qing Hao, Ruicen Li, Hancong Li, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 5
Qing Hao, Ruicen Li, Hancong Li, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 5
Immune Regulatory Networks and Therapy of γδ T Cells in Liver Cancer: Recent Trends and Advancements
Kun-Li Yin, Kai-Jian Chu, Ming O. Li, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 4
Kun-Li Yin, Kai-Jian Chu, Ming O. Li, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 4
The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients
Junhui Tang, Ming Liang, Feiyu Qin, et al.
Immunobiology (2024) Vol. 229, Iss. 3, pp. 152805-152805
Open Access | Times Cited: 4
Junhui Tang, Ming Liang, Feiyu Qin, et al.
Immunobiology (2024) Vol. 229, Iss. 3, pp. 152805-152805
Open Access | Times Cited: 4
CD69+ Vδ1γδ T cells are anti-tumor subpopulations in hepatocellular carcinoma
Hongqin You, Yixin Wang, Xiaokun Wang, et al.
Molecular Immunology (2024) Vol. 172, pp. 76-84
Closed Access | Times Cited: 4
Hongqin You, Yixin Wang, Xiaokun Wang, et al.
Molecular Immunology (2024) Vol. 172, pp. 76-84
Closed Access | Times Cited: 4
Human γδ T cells in the tumor microenvironment: Key insights for advancing cancer immunotherapy
Won Hyung Park, Heung Kyu Lee
Molecules and Cells (2025), pp. 100177-100177
Open Access
Won Hyung Park, Heung Kyu Lee
Molecules and Cells (2025), pp. 100177-100177
Open Access
Tissue-resident immune cells: from defining characteristics to roles in diseases
Jia Li, Xiao Chu, Chunxiang Li, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Jia Li, Xiao Chu, Chunxiang Li, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy
Valentina Cazzetta, Delphine Depierreux, Francesco Colucci, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1264-1264
Open Access | Times Cited: 10
Valentina Cazzetta, Delphine Depierreux, Francesco Colucci, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1264-1264
Open Access | Times Cited: 10
High-dimensional in situ proteomics imaging to assess γδ T cells in spatial biology
Nicola Herold, Matthias Bruhns, Sepideh Babaei, et al.
Journal of Leukocyte Biology (2024) Vol. 115, Iss. 4, pp. 750-759
Closed Access | Times Cited: 3
Nicola Herold, Matthias Bruhns, Sepideh Babaei, et al.
Journal of Leukocyte Biology (2024) Vol. 115, Iss. 4, pp. 750-759
Closed Access | Times Cited: 3
A radiomics model to predict γδ T‐cell abundance and overall survival in head and neck squamous cell carcinoma
Binna Fan, Binting Fan, Na Sun, et al.
The FASEB Journal (2024) Vol. 38, Iss. 5
Closed Access | Times Cited: 3
Binna Fan, Binting Fan, Na Sun, et al.
The FASEB Journal (2024) Vol. 38, Iss. 5
Closed Access | Times Cited: 3
The role of γδT lymphocytes in atherosclerosis
LiMin Xu, Fanfan Chen, Wei Fan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
LiMin Xu, Fanfan Chen, Wei Fan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Systematic analysis of human colorectal cancer scRNA-seq revealed limited pro-tumoral IL-17 production potential in gamma delta T cells
Ran Ran, Martin Trapečar, Douglas K. Brubaker
Neoplasia (2024) Vol. 58, pp. 101072-101072
Open Access | Times Cited: 3
Ran Ran, Martin Trapečar, Douglas K. Brubaker
Neoplasia (2024) Vol. 58, pp. 101072-101072
Open Access | Times Cited: 3
Unique Profile of Proinflammatory Cytokines in Plasma of Drug-Naïve Individuals with Advanced HIV/TB Co-Infection
Marina Nosik, Maria G. Belikova, Konstantin Ryzhov, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1330-1330
Open Access | Times Cited: 7
Marina Nosik, Maria G. Belikova, Konstantin Ryzhov, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1330-1330
Open Access | Times Cited: 7
Unraveling the secrets of γδ T cells with single-cell biology
Sagar Sagar
Journal of Leukocyte Biology (2023) Vol. 115, Iss. 1, pp. 47-56
Open Access | Times Cited: 7
Sagar Sagar
Journal of Leukocyte Biology (2023) Vol. 115, Iss. 1, pp. 47-56
Open Access | Times Cited: 7
Distinct subsets of Vδ1 effector and Vδ2 γδ T cells shift in frequency and are linked to plasma inflammatory markers during ART-suppressed HIV infection
Riley M.F. Pihl, Erika L. Smith-Mahoney, Alex Olson, et al.
The Journal of Infectious Diseases (2024) Vol. 229, Iss. 5, pp. 1317-1327
Closed Access | Times Cited: 2
Riley M.F. Pihl, Erika L. Smith-Mahoney, Alex Olson, et al.
The Journal of Infectious Diseases (2024) Vol. 229, Iss. 5, pp. 1317-1327
Closed Access | Times Cited: 2
Harnessing γδ T Cells against Human Gynecologic Cancers
José R. Conejo-García, Carmen M. Anadon, Luis Lopez‐Bailon, et al.
Life (2024) Vol. 14, Iss. 3, pp. 325-325
Open Access | Times Cited: 2
José R. Conejo-García, Carmen M. Anadon, Luis Lopez‐Bailon, et al.
Life (2024) Vol. 14, Iss. 3, pp. 325-325
Open Access | Times Cited: 2
Multilayered Immunity by Tissue-Resident Lymphocytes in Cancer
Ming O. Li, Jing Zhang, Zijian Xu, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 647-677
Closed Access | Times Cited: 2
Ming O. Li, Jing Zhang, Zijian Xu, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 647-677
Closed Access | Times Cited: 2